Recombinant pro-apoptotic Mycobacterium tuberculosis generates CD8+ T cell responses against human immunodeficiency virus type 1 Env and M. tuberculosis in neonatal mice
- 4 October 2009
- journal article
- research article
- Published by Elsevier BV in Vaccine
- Vol. 28 (1), 152-161
- https://doi.org/10.1016/j.vaccine.2009.09.087
Abstract
No abstract availableKeywords
This publication has 55 references indexed in Scilit:
- Protective T cell immunity against respiratory syncytial virus is efficiently induced by recombinant BCGProceedings of the National Academy of Sciences, 2008
- Immune control of an SIV challenge by a T-cell-based vaccine in rhesus monkeysNature, 2008
- Safety and Immunogenicity of a New Tuberculosis Vaccine, MVA85A, in Healthy Adults in South AfricaThe Journal of Infectious Diseases, 2008
- Vaccine Platform for Prevention of Tuberculosis and Mother-to-Child Transmission of Human Immunodeficiency Virus Type 1 through BreastfeedingJournal of Virology, 2007
- Enhanced priming of adaptive immunity by a proapoptotic mutant of Mycobacterium tuberculosisJCI Insight, 2007
- CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cellsThe Journal of Experimental Medicine, 2006
- Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectivenessThe Lancet, 2006
- Safety and Immunogenicity of an HIV‐1 Recombinant Canarypox Vaccine in Newborns and Infants of HIV‐1–Infected WomenThe Journal of Infectious Diseases, 2005
- Inhibitory Effects of IFN-γ on HIV-1 Replication in Latently Infected CellsBiochemical and Biophysical Research Communications, 2002
- Human Immunodeficiency Virus Type 1 (HIV‐1) gp120–Specific Antibodies in Neonates Receiving an HIV‐1 Recombinant gp120 VaccineThe Journal of Infectious Diseases, 2001